CSTL
Ticker
Castle Biosciences Inc
Company
Diagnostics
Industry
Healthcare
Sector
Financial Ratio Analysis
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
β€”65.7%127.6%20.8%50.2%45.7%60.4%51.1%β€”10.1%
Revenue Growth QoQ
β€”65.7%127.6%20.8%50.2%45.7%60.4%51.1%β€”β€”
Gross Margin
64.2%76.8%85.9%84.5%83.2%76.6%79.5%81.9%β€”79.9%
EBITDA Margin
-77.0%-15.4%14.8%-9.7%-39.0%-45.5%-25.3%7.4%β€”2.3%
Operating Margin
-79.2%-16.8%14.1%-10.4%-42.6%-53.2%-30.9%2.6%β€”-10.2%
Profit Margin
-89.9%-27.9%10.2%-16.4%-33.3%-49.0%-26.1%5.5%β€”-3.6%
FCF / EBITDA
120.2%357.9%79.1%-84.3%61.3%75.9%34.6%148.1%β€”324.1%